The weekly litigation news digest is live. Subscribe now

IP Verse

Hbv Antisense Inhibitors - EP2512491

The patent EP2512491 was granted to Glaxo Group on Oct 11, 2017. The application was originally filed on Oct 15, 2010 under application number EP10824199A. The patent is currently recorded with a legal status of "Revoked".

EP2512491

GLAXO GROUP
Application Number
EP10824199A
Filing Date
Oct 15, 2010
Status
Revoked
Apr 17, 2020
Publication Date
Oct 11, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ROCHEJul 10, 2018D YOUNG -

Patent Citations (18) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTUS2003148985
INTERNATIONAL-SEARCH-REPORTUS2005014712
INTERNATIONAL-SEARCH-REPORTUS2006128646
OPPOSITIONUS2003068301
OPPOSITIONUS2003139363
OPPOSITIONUS2003206887
OPPOSITIONUS2004054156
OPPOSITIONUS2007032441
OPPOSITIONUS2009137500
OPPOSITIONWO0116312
OPPOSITIONWO2012024170
OPPOSITIONWO2012145674
OPPOSITIONWO2015173208
OPPOSITIONWO9639502
OPPOSITIONWO9703211
SEARCHUS2003206887
SEARCHUS5985662
SEARCHWO2004078181

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents